Welcome to DrugBank 4.0! If you prefer, you can still go back to version 3.0.
Identification
NameSwainsonine
Accession NumberDB02034  (EXPT02983)
Typesmall molecule
Groupsexperimental
Description

An indolizidine alkaloid from the plant Swainsona canescens that is a potent alpha-mannosidase inhibitor. Swainsonine also exhibits antimetastatic, antiproliferative, and immunomodulatory activity. [PubChem]

Structure
Thumb
SynonymsNot Available
SaltsNot Available
Brand namesNot Available
Brand mixturesNot Available
CategoriesNot Available
CAS number72741-87-8
WeightAverage: 173.2096
Monoisotopic: 173.105193351
Chemical FormulaC8H15NO3
InChI KeyInChIKey=FXUAIOOAOAVCGD-FKSUSPILSA-N
InChI
InChI=1S/C8H15NO3/c10-5-2-1-3-9-4-6(11)8(12)7(5)9/h5-8,10-12H,1-4H2/t5-,6+,7-,8+/m0/s1
IUPAC Name
(1S,2R,8S,8aS)-octahydroindolizine-1,2,8-triol
SMILES
O[C@@H]1CN2CCC[C@H](O)[C@H]2[C@@H]1O
Mass SpecNot Available
Taxonomy
KingdomOrganic Compounds
SuperclassHeterocyclic Compounds
ClassIndolizidines
SubclassNot Available
Direct parentIndolizidines
Alternative parentsPiperidines; Pyrrolidines; Tertiary Amines; 1,2-Diols; Secondary Alcohols; Polyamines
Substituentspiperidine; pyrrolidine; tertiary amine; secondary alcohol; polyol; 1,2-diol; polyamine; amine; alcohol; organonitrogen compound
Classification descriptionThis compound belongs to the indolizidines. These are polycyclic compounds containing an indolizidine, which is a bicyclic heterocycle containing a saturated six-member ring fused to a saturated five-member ring, one of the bridging atoms being nitrogen.
Pharmacology
IndicationNot Available
PharmacodynamicsNot Available
Mechanism of actionNot Available
AbsorptionNot Available
Volume of distributionNot Available
Protein bindingNot Available
Metabolism
Route of eliminationNot Available
Half lifeNot Available
ClearanceNot Available
ToxicityNot Available
Affected organismsNot Available
PathwaysNot Available
SNP Mediated EffectsNot Available
SNP Mediated Adverse Drug ReactionsNot Available
ADMET
Predicted ADMET features
Property Value Probability
Human Intestinal Absorption + 0.9652
Blood Brain Barrier + 0.5273
Caco-2 permeable - 0.5141
P-glycoprotein substrate Substrate 0.6622
P-glycoprotein inhibitor I Non-inhibitor 0.8542
P-glycoprotein inhibitor II Non-inhibitor 0.9732
Renal organic cation transporter Non-inhibitor 0.6424
CYP450 2C9 substrate Non-substrate 0.8769
CYP450 2D6 substrate Non-substrate 0.6593
CYP450 3A4 substrate Non-substrate 0.5136
CYP450 1A2 substrate Non-inhibitor 0.7861
CYP450 2C9 substrate Non-inhibitor 0.9292
CYP450 2D6 substrate Non-inhibitor 0.9075
CYP450 2C19 substrate Non-inhibitor 0.9214
CYP450 3A4 substrate Non-inhibitor 0.9972
CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9921
Ames test Non AMES toxic 0.7576
Carcinogenicity Non-carcinogens 0.9722
Biodegradation Not ready biodegradable 0.9773
Rat acute toxicity 2.3774 LD50, mol/kg Not applicable
hERG inhibition (predictor I) Weak inhibitor 0.6501
hERG inhibition (predictor II) Non-inhibitor 0.8976
Pharmacoeconomics
ManufacturersNot Available
PackagersNot Available
Dosage formsNot Available
PricesNot Available
PatentsNot Available
Properties
Statesolid
Experimental Properties
PropertyValueSource
melting point143-144 °CNot Available
Predicted Properties
PropertyValueSource
water solubility1.32e+03 g/lALOGPS
logP-1.5ALOGPS
logP-1.4ChemAxon
logS0.88ALOGPS
pKa (strongest acidic)13.28ChemAxon
pKa (strongest basic)9.47ChemAxon
physiological charge1ChemAxon
hydrogen acceptor count4ChemAxon
hydrogen donor count3ChemAxon
polar surface area63.93ChemAxon
rotatable bond count0ChemAxon
refractivity43.12ChemAxon
polarizability18.07ChemAxon
number of rings2ChemAxon
bioavailability1ChemAxon
rule of fiveYesChemAxon
Ghose filterNoChemAxon
Veber's ruleNoChemAxon
MDDR-like ruleNoChemAxon
Spectra
SpectraNot Available
References
Synthesis Reference

William H. Pearson, Erik J. Hembre, “Method for preparing swainsonine.” U.S. Patent US5919952, issued December, 1986.

US5919952
General ReferenceNot Available
External Links
ResourceLink
KEGG CompoundC10173
PubChem Compound10975968
PubChem Substance46506581
ChemSpider5170
HETSWA
WikipediaSwainsonine
ATC CodesNot Available
AHFS CodesNot Available
PDB Entries
FDA labelNot Available
MSDSNot Available
Interactions
Drug InteractionsNot Available
Food InteractionsNot Available

1. Alpha-mannosidase 2

Kind: protein

Organism: Human

Pharmacological action: unknown

Components

Name UniProt ID Details
Alpha-mannosidase 2 Q16706 Details

References:

  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. Pubmed
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. Pubmed
  3. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. Pubmed

Comments
Drug created on June 13, 2005 07:24 / Updated on September 16, 2013 17:17